Global Mesalazine Market Growth 2021-2026

Publisher Name :
Date: 28-Jun-2021
No. of pages: 116

According to this latest study, the 2021 growth of Mesalazine will have significant change from previous year. By the most conservative estimates of global Mesalazine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 139.3 million in 2020. Over the next five years the Mesalazine market will register a 4.3% CAGR in terms of revenue, the global market size will reach US$ 164.6 million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Mesalazine market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.

- Purity ? 97 %

- Purity ? 98 %

- Purity ? 99 %

- According to the type, purity ? 98% is the highest, reaching 48.44% in 2019.

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.

- Tablets

- Capsules

- Pellet and Granule

- Suppository

- Enema

- Others

- Mesalazine tablets has the highest market share in terms of application, at 50.61% in 2019.

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.

- PharmaZell

- Syntese A/S

- Cambrex Corporation

- Divis Laboratories

- Chemi SpA

- Ipca Laboratories

- Hangzhou Brother

- Lianyungang Fengheng Biopharm

- Lasa Loboratory

- Corden Pharma Bergamo

- Erregierre SpA

- CTX Lifescience

- Ishita Active Pharma Ingredients

- YC Biotech (Jiangsu)

- Xinxiang Tianfeng Fine Chemical

Global Mesalazine Market Growth 2021-2026

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Mesalazine Consumption 2016-2026
2.1.2 Mesalazine Consumption CAGR by Region
2.2 Mesalazine Segment by Type
2.2.1 Purity ? 97 %
2.2.2 Purity ? 98 %
2.2.3 Purity ? 99 %
2.3 Mesalazine Sales by Type
2.3.1 Global Mesalazine Sales Market Share by Type (2016-2021)
2.3.2 Global Mesalazine Revenue and Market Share by Type (2016-2021)
2.3.3 Global Mesalazine Sale Price by Type (2016-2021)
2.4 Mesalazine Segment by Application
2.4.1 Tablets
2.4.2 Capsules
2.4.3 Pellet and Granule
2.4.4 Suppository
2.4.5 Enema
2.4.6 Others
2.5 Mesalazine Sales by Application
2.5.1 Global Mesalazine Sale Market Share by Application (2016-2021)
2.5.2 Global Mesalazine Revenue and Market Share by Application (2016-2021)
2.5.3 Global Mesalazine Sale Price by Application (2016-2021)

3 Global Mesalazine by Company
3.1 Global Mesalazine Sales Market Share by Company
3.1.1 Global Mesalazine Sales by Company (2019-2021)
3.1.2 Global Mesalazine Sales Market Share by Company (2019-2021)
3.2 Global Mesalazine Revenue Market Share by Company
3.2.1 Global Mesalazine Revenue by Company (2019-2021)
3.2.2 Global Mesalazine Revenue Market Share by Company (2019-2021)
3.3 Global Mesalazine Sale Price by Company
3.4 Global Manufacturers Mesalazine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Mesalazine Product Location Distribution
3.4.2 Players Mesalazine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Mesalazine by Region
4.1 Global Mesalazine by Region
4.1.1 Global Mesalazine Sales by Region
4.1.2 Global Mesalazine Revenue by Region
4.2 Americas Mesalazine Sales Growth
4.3 APAC Mesalazine Sales Growth
4.4 Europe Mesalazine Sales Growth
4.5 Middle East & Africa Mesalazine Sales Growth

5 Americas
5.1 Americas Mesalazine Sales by Country
5.1.1 Americas Mesalazine Sales by Country (2016-2021)
5.1.2 Americas Mesalazine Revenue by Country (2016-2021)
5.2 Americas Mesalazine Sales by Type
5.3 Americas Mesalazine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Mesalazine Sales by Region
6.1.1 APAC Mesalazine Sales by Region (2016-2021)
6.1.2 APAC Mesalazine Revenue by Region (2016-2021)
6.2 APAC Mesalazine Sales by Type
6.3 APAC Mesalazine Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Mesalazine by Country
7.1.1 Europe Mesalazine Sales by Country (2016-2021)
7.1.2 Europe Mesalazine Revenue by Country (2016-2021)
7.2 Europe Mesalazine Sales by Type
7.3 Europe Mesalazine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Mesalazine by Country
8.1.1 Middle East & Africa Mesalazine Sales by Country (2016-2021)
8.1.2 Middle East & Africa Mesalazine Revenue by Country (2016-2021)
8.2 Middle East & Africa Mesalazine Sales by Type
8.3 Middle East & Africa Mesalazine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Mesalazine Distributors
10.3 Mesalazine Customer

11 Global Mesalazine Market Forecast
11.1 Global Mesalazine Forecast by Region
11.1.1 Global Mesalazine Forecast by Regions (2021-2026)
11.2.2 Global Mesalazine Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Mesalazine Forecast by Type
11.7 Global Mesalazine Forecast by Application

12 Key Players Analysis
12.1 PharmaZell
12.1.1 PharmaZell Company Information
12.1.2 PharmaZell Mesalazine Product Offered
12.1.3 PharmaZell Mesalazine Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 PharmaZell Main Business Overview
12.1.5 PharmaZell Latest Developments
12.2 Syntese A/S
12.2.1 Syntese A/S Company Information
12.2.2 Syntese A/S Mesalazine Product Offered
12.2.3 Syntese A/S Mesalazine Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Syntese A/S Main Business Overview
12.2.5 Syntese A/S Latest Developments
12.3 Cambrex Corporation
12.3.1 Cambrex Corporation Company Information
12.3.2 Cambrex Corporation Mesalazine Product Offered
12.3.3 Cambrex Corporation Mesalazine Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Cambrex Corporation Main Business Overview
12.3.5 Cambrex Corporation Latest Developments
12.4 Divis Laboratories
12.4.1 Divis Laboratories Company Information
12.4.2 Divis Laboratories Mesalazine Product Offered
12.4.3 Divis Laboratories Mesalazine Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Divis Laboratories Main Business Overview
12.4.5 Divis Laboratories Latest Developments
12.5 Chemi SpA
12.5.1 Chemi SpA Company Information
12.5.2 Chemi SpA Mesalazine Product Offered
12.5.3 Chemi SpA Mesalazine Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Chemi SpA Main Business Overview
12.5.5 Chemi SpA Latest Developments
12.6 Ipca Laboratories
12.6.1 Ipca Laboratories Company Information
12.6.2 Ipca Laboratories Mesalazine Product Offered
12.6.3 Ipca Laboratories Mesalazine Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Ipca Laboratories Main Business Overview
12.6.5 Ipca Laboratories Latest Developments
12.7 Hangzhou Brother
12.7.1 Hangzhou Brother Company Information
12.7.2 Hangzhou Brother Mesalazine Product Offered
12.7.3 Hangzhou Brother Mesalazine Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Hangzhou Brother Main Business Overview
12.7.5 Hangzhou Brother Latest Developments
12.8 Lianyungang Fengheng Biopharm
12.8.1 Lianyungang Fengheng Biopharm Company Information
12.8.2 Lianyungang Fengheng Biopharm Mesalazine Product Offered
12.8.3 Lianyungang Fengheng Biopharm Mesalazine Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Lianyungang Fengheng Biopharm Main Business Overview
12.8.5 Lianyungang Fengheng Biopharm Latest Developments
12.9 Lasa Loboratory
12.9.1 Lasa Loboratory Company Information
12.9.2 Lasa Loboratory Mesalazine Product Offered
12.9.3 Lasa Loboratory Mesalazine Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Lasa Loboratory Main Business Overview
12.9.5 Lasa Loboratory Latest Developments
12.10 Corden Pharma Bergamo
12.10.1 Corden Pharma Bergamo Company Information
12.10.2 Corden Pharma Bergamo Mesalazine Product Offered
12.10.3 Corden Pharma Bergamo Mesalazine Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Corden Pharma Bergamo Main Business Overview
12.10.5 Corden Pharma Bergamo Latest Developments
12.11 Erregierre SpA
12.11.1 Erregierre SpA Company Information
12.11.2 Erregierre SpA Mesalazine Product Offered
12.11.3 Erregierre SpA Mesalazine Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Erregierre SpA Main Business Overview
12.11.5 Erregierre SpA Latest Developments
12.12 CTX Lifescience
12.12.1 CTX Lifescience Company Information
12.12.2 CTX Lifescience Mesalazine Product Offered
12.12.3 CTX Lifescience Mesalazine Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 CTX Lifescience Main Business Overview
12.12.5 CTX Lifescience Latest Developments
12.13 Ishita Active Pharma Ingredients
12.13.1 Ishita Active Pharma Ingredients Company Information
12.13.2 Ishita Active Pharma Ingredients Mesalazine Product Offered
12.13.3 Ishita Active Pharma Ingredients Mesalazine Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 Ishita Active Pharma Ingredients Main Business Overview
12.13.5 Ishita Active Pharma Ingredients Latest Developments
12.14 YC Biotech (Jiangsu)
12.14.1 YC Biotech (Jiangsu) Company Information
12.14.2 YC Biotech (Jiangsu) Mesalazine Product Offered
12.14.3 YC Biotech (Jiangsu) Mesalazine Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 YC Biotech (Jiangsu) Main Business Overview
12.14.5 YC Biotech (Jiangsu) Latest Developments
12.15 Xinxiang Tianfeng Fine Chemical
12.15.1 Xinxiang Tianfeng Fine Chemical Company Information
12.15.2 Xinxiang Tianfeng Fine Chemical Mesalazine Product Offered
12.15.3 Xinxiang Tianfeng Fine Chemical Mesalazine Sales, Revenue, Price and Gross Margin (2019-2021)
12.15.4 Xinxiang Tianfeng Fine Chemical Main Business Overview
12.15.5 Xinxiang Tianfeng Fine Chemical Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Mesalazine Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Purity ? 97 %
Table 3. Major Players of Purity ? 98 %
Table 4. Major Players of Purity ? 99 %
Table 5. Global Mesalazine Sales by Type (2016-2021) & (Ton)
Table 6. Global Mesalazine Sales Market Share by Type (2016-2021)
Table 7. Global Mesalazine Revenue by Type (2016-2021) & ($ million)
Table 8. Global Mesalazine Revenue Market Share by Type (2016-2021)
Table 9. Global Mesalazine Sale Price by Type (2016-2021)
Table 10. Global Mesalazine Sales by Application (2016-2021) & (Ton)
Table 11. Global Mesalazine Sales Market Share by Application (2016-2021)
Table 12. Global Mesalazine Value by Application (2016-2021)
Table 13. Global Mesalazine Revenue Market Share by Application (2016-2021)
Table 14. Global Mesalazine Sale Price by Application (2016-2021)
Table 15. Global Mesalazine Sales by Company (2019-2021) & (Ton)
Table 16. Global Mesalazine Sales Market Share by Company (2019-2021)
Table 17. Global Mesalazine Revenue by Company (2019-2021) ($ Millions)
Table 18. Global Mesalazine Revenue Market Share by Company (2019-2021)
Table 19. Global Mesalazine Sale Price by Company (2019-2021)
Table 20. Key Manufacturers Mesalazine Producing Area Distribution and Sales Area
Table 21. Players Mesalazine Products Offered
Table 22. Mesalazine Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Mesalazine Sales by Region (2016-2021) (Ton)
Table 26. Global Mesalazine Sales Market Share by Region (2016-2021)
Table 27. Global Mesalazine Revenue by Region (2016-2021) & ($ Millions)
Table 28. Global Mesalazine Revenue Market Share by Region (2016-2021)
Table 29. Americas Mesalazine Sales by Country (2016-2021) & (Ton)
Table 30. Americas Mesalazine Sales Market Share by Country (2016-2021)
Table 31. Americas Mesalazine Revenue by Country (2016-2021) & ($ Millions)
Table 32. Americas Mesalazine Revenue Market Share by Country (2016-2021)
Table 33. Americas Mesalazine Sales by Type (2016-2021) & (Ton)
Table 34. Americas Mesalazine Sales Market Share by Type (2016-2021)
Table 35. Americas Mesalazine Sales by Application (2016-2021) & (Ton)
Table 36. Americas Mesalazine Sales Market Share by Application (2016-2021)
Table 37. APAC Mesalazine Sales by Region (2016-2021) & (Ton)
Table 38. APAC Mesalazine Sales Market Share by Region (2016-2021)
Table 39. APAC Mesalazine Revenue by Region (2016-2021) & ($ Millions)
Table 40. APAC Mesalazine Revenue Market Share by Region (2016-2021)
Table 41. APAC Mesalazine Sales by Type (2016-2021) & (Ton)
Table 42. APAC Mesalazine Sales Market Share by Type (2016-2021)
Table 43. APAC Mesalazine Sales by Application (2016-2021) & (Ton)
Table 44. APAC Mesalazine Sales Market Share by Application (2016-2021)
Table 45. Europe Mesalazine Sales by Country (2016-2021) & (Ton)
Table 46. Europe Mesalazine Sales Market Share by Country (2016-2021)
Table 47. Europe Mesalazine Revenue by Country (2016-2021) & ($ Millions)
Table 48. Europe Mesalazine Revenue Market Share by Country (2016-2021)
Table 49. Europe Mesalazine Sales by Type (2016-2021) & (Ton)
Table 50. Europe Mesalazine Sales Market Share by Type (2016-2021)
Table 51. Europe Mesalazine Sales by Application (2016-2021) & (Ton)
Table 52. Europe Mesalazine Sales Market Share by Application (2016-2021)
Table 53. Middle East & Africa Mesalazine Sales by Country (2016-2021) & (Ton)
Table 54. Middle East & Africa Mesalazine Sales Market Share by Country (2016-2021)
Table 55. Middle East & Africa Mesalazine Revenue by Country (2016-2021) & ($ Millions)
Table 56. Middle East & Africa Mesalazine Revenue Market Share by Country (2016-2021)
Table 57. Middle East & Africa Mesalazine Sales by Type (2016-2021) & (Ton)
Table 58. Middle East & Africa Mesalazine Sales Market Share by Type (2016-2021)
Table 59. Middle East & Africa Mesalazine Sales by Application (2016-2021) & (Ton)
Table 60. Middle East & Africa Mesalazine Sales Market Share by Application (2016-2021)
Table 61. Key and Potential Regions of Mesalazine
Table 62. Key Application and Potential Industries of Mesalazine
Table 63. Key Challenges of Mesalazine
Table 64. Key Trends of Mesalazine
Table 65. Mesalazine Distributors List
Table 66. Mesalazine Customer List
Table 67. Global Mesalazine Sales Forecast by Region (2021-2026) & (Ton)
Table 68. Global Mesalazine Consumption Market Forecast by Region
Table 69. Global Mesalazine Revenue Forecast by Region (2021-2026) & ($ millions)
Table 70. Global Mesalazine Revenue Market Share Forecast by Region (2021-2026)
Table 71. Americas Mesalazine Sales Forecast by Country (2021-2026) & (Ton)
Table 72. Americas Mesalazine Revenue Forecast by Country (2021-2026) & ($ millions)
Table 73. APAC Mesalazine Sales Forecast by Region (2021-2026) & (Ton)
Table 74. APAC Mesalazine Revenue Forecast by Region (2021-2026) & ($ millions)
Table 75. Europe Mesalazine Sales Forecast by Country (2021-2026) & (Ton)
Table 76. Europe Mesalazine Revenue Forecast by Country (2021-2026) & ($ millions)
Table 77. Middle East & Africa Mesalazine Sales Forecast by Country (2021-2026) & (Ton)
Table 78. Middle East & Africa Mesalazine Revenue Forecast by Country (2021-2026) & ($ millions)
Table 79. Global Mesalazine Sales Forecast by Type (2021-2026) & (Ton)
Table 80. Global Mesalazine Sales Market Share Forecast by Type (2021-2026)
Table 81. Global Mesalazine Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 82. Global Mesalazine Revenue Market Share Forecast by Type (2021-2026)
Table 83. Global Mesalazine Sales Forecast by Application (2021-2026) & (Ton)
Table 84. Global Mesalazine Sales Market Share Forecast by Application (2021-2026)
Table 85. Global Mesalazine Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 86. Global Mesalazine Revenue Market Share Forecast by Application (2021-2026)
Table 87. PharmaZell Basic Information, Mesalazine Manufacturing Base, Sales Area and Its Competitors
Table 88. PharmaZell Mesalazine Product Offered
Table 89. PharmaZell Mesalazine Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2021E)
Table 90. PharmaZell Main Business
Table 91. PharmaZell Latest Developments
Table 92. Syntese A/S Basic Information, Mesalazine Manufacturing Base, Sales Area and Its Competitors
Table 93. Syntese A/S Mesalazine Product Offered
Table 94. Syntese A/S Mesalazine Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2021E)
Table 95. Syntese A/S Main Business
Table 96. Syntese A/S Latest Developments
Table 97. Cambrex Corporation Basic Information, Mesalazine Manufacturing Base, Sales Area and Its Competitors
Table 98. Cambrex Corporation Mesalazine Product Offered
Table 99. Cambrex Corporation Mesalazine Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2021E)
Table 100. Cambrex Corporation Main Business
Table 101. Cambrex Corporation Latest Developments
Table 102. Divis Laboratories Basic Information, Mesalazine Manufacturing Base, Sales Area and Its Competitors
Table 103. Divis Laboratories Mesalazine Product Offered
Table 104. Divis Laboratories Mesalazine Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2021E)
Table 105. Divis Laboratories Main Business
Table 106. Divis Laboratories Latest Developments
Table 107. Chemi SpA Basic Information, Mesalazine Manufacturing Base, Sales Area and Its Competitors
Table 108. Chemi SpA Mesalazine Product Offered
Table 109. Chemi SpA Mesalazine Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2021E)
Table 110. Chemi SpA Main Business
Table 111. Chemi SpA Latest Developments
Table 112. Ipca Laboratories Basic Information, Mesalazine Manufacturing Base, Sales Area and Its Competitors
Table 113. Ipca Laboratories Mesalazine Product Offered
Table 114. Ipca Laboratories Mesalazine Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2021E)
Table 115. Ipca Laboratories Main Business
Table 116. Ipca Laboratories Latest Developments
Table 117. Hangzhou Brother Basic Information, Mesalazine Manufacturing Base, Sales Area and Its Competitors
Table 118. Hangzhou Brother Mesalazine Product Offered
Table 119. Hangzhou Brother Mesalazine Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2021E)
Table 120. Hangzhou Brother Main Business
Table 121. Hangzhou Brother Latest Developments
Table 122. Lianyungang Fengheng Biopharm Basic Information, Mesalazine Manufacturing Base, Sales Area and Its Competitors
Table 123. Lianyungang Fengheng Biopharm Mesalazine Product Offered
Table 124. Lianyungang Fengheng Biopharm Mesalazine Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2021E)
Table 125. Lianyungang Fengheng Biopharm Main Business
Table 126. Lianyungang Fengheng Biopharm Latest Developments
Table 127. Lasa Loboratory Basic Information, Mesalazine Manufacturing Base, Sales Area and Its Competitors
Table 128. Lasa Loboratory Mesalazine Product Offered
Table 129. Lasa Loboratory Mesalazine Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2021E)
Table 130. Lasa Loboratory Main Business
Table 131. Lasa Loboratory Latest Developments
Table 132. Corden Pharma Bergamo Basic Information, Mesalazine Manufacturing Base, Sales Area and Its Competitors
Table 133. Corden Pharma Bergamo Mesalazine Product Offered
Table 134. Corden Pharma Bergamo Mesalazine Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2021E)
Table 135. Corden Pharma Bergamo Main Business
Table 136. Corden Pharma Bergamo Latest Developments
Table 137. Erregierre SpA Basic Information, Mesalazine Manufacturing Base, Sales Area and Its Competitors
Table 138. Erregierre SpA Mesalazine Product Offered
Table 139. Erregierre SpA Mesalazine Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2021E)
Table 140. Erregierre SpA Main Business
Table 141. Erregierre SpA Latest Developments
Table 142. CTX Lifescience Basic Information, Mesalazine Manufacturing Base, Sales Area and Its Competitors
Table 143. CTX Lifescience Mesalazine Product Offered
Table 144. CTX Lifescience Mesalazine Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2021E)
Table 145. CTX Lifescience Main Business
Table 146. CTX Lifescience Latest Developments
Table 147. Ishita Active Pharma Ingredients Basic Information, Mesalazine Manufacturing Base, Sales Area and Its Competitors
Table 148. Ishita Active Pharma Ingredients Mesalazine Product Offered
Table 149. Ishita Active Pharma Ingredients Mesalazine Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2021E)
Table 150. Ishita Active Pharma Ingredients Main Business
Table 151. Ishita Active Pharma Ingredients Latest Developments
Table 152. YC Biotech (Jiangsu) Basic Information, Mesalazine Manufacturing Base, Sales Area and Its Competitors
Table 153. YC Biotech (Jiangsu) Mesalazine Product Offered
Table 154. YC Biotech (Jiangsu) Mesalazine Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2021E)
Table 155. YC Biotech (Jiangsu) Main Business
Table 156. YC Biotech (Jiangsu) Latest Developments
Table 157. Xinxiang Tianfeng Fine Chemical Basic Information, Mesalazine Manufacturing Base, Sales Area and Its Competitors
Table 158. Xinxiang Tianfeng Fine Chemical Mesalazine Product Offered
Table 159. Xinxiang Tianfeng Fine Chemical Mesalazine Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2021E)
Table 160. Xinxiang Tianfeng Fine Chemical Main Business
Table 161. Xinxiang Tianfeng Fine Chemical Latest Developments
List of Figures
Figure 1. Picture of Mesalazine
Figure 2. Mesalazine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Mesalazine Sales Growth Rate 2016-2026 (Ton)
Figure 7. Global Mesalazine Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Mesalazine Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Purity ? 97 %
Figure 10. Product Picture of Purity ? 98 %
Figure 11. Product Picture of Purity ? 99 %
Figure 12. Global Mesalazine Sales Market Share by Type in 2020
Figure 13. Global Mesalazine Revenue Market Share by Type (2016-2021)
Figure 14. Mesalazine Consumed in Tablets
Figure 15. Global Mesalazine Market: Tablets (2016-2021) & (Ton)
Figure 16. Mesalazine Consumed in Capsules
Figure 17. Global Mesalazine Market: Capsules (2016-2021) & (Ton)
Figure 18. Mesalazine Consumed in Pellet and Granule
Figure 19. Global Mesalazine Market: Pellet and Granule (2016-2021) & (Ton)
Figure 20. Mesalazine Consumed in Suppository
Figure 21. Global Mesalazine Market: Suppository (2016-2021) & (Ton)
Figure 22. Mesalazine Consumed in Enema
Figure 23. Global Mesalazine Market: Enema (2016-2021) & (Ton)
Figure 24. Mesalazine Consumed in Others
Figure 25. Global Mesalazine Market: Others (2016-2021) & (Ton)
Figure 26. Global Mesalazine Sales Market Share by Application (2016-2021)
Figure 27. Global Mesalazine Revenue Market Share by Application in 2020
Figure 28. Mesalazine Revenue Market by Company in 2020 ($ Million)
Figure 29. Global Mesalazine Revenue Market Share by Company in 2020
Figure 30. Global Mesalazine Sales Market Share by Regions (2016-2021)
Figure 31. Global Mesalazine Revenue Market Share by Region in 2020
Figure 32. Americas Mesalazine Sales 2016-2021 (Ton)
Figure 33. Americas Mesalazine Revenue 2016-2021 ($ Millions)
Figure 34. APAC Mesalazine Sales 2016-2021 (Ton)
Figure 35. APAC Mesalazine Revenue 2016-2021 ($ Millions)
Figure 36. Europe Mesalazine Sales 2016-2021 (Ton)
Figure 37. Europe Mesalazine Revenue 2016-2021 ($ Millions)
Figure 38. Middle East & Africa Mesalazine Sales 2016-2021 (Ton)
Figure 39. Middle East & Africa Mesalazine Revenue 2016-2021 ($ Millions)
Figure 40. Americas Mesalazine Sales Market Share by Country in 2020
Figure 41. Americas Mesalazine Revenue Market Share by Country in 2020
Figure 42. Americas Mesalazine Sales Market Share by Type in 2020
Figure 43. Americas Mesalazine Sales Market Share by Application in 2020
Figure 44. United States Mesalazine Revenue Growth 2016-2021 ($ Millions)
Figure 45. Canada Mesalazine Revenue Growth 2016-2021 ($ Millions)
Figure 46. Mexico Mesalazine Revenue Growth 2016-2021 ($ Millions)
Figure 47. Brazil Mesalazine Revenue Growth 2016-2021 ($ Millions)
Figure 48. APAC Mesalazine Sales Market Share by Region in 2020
Figure 49. APAC Mesalazine Revenue Market Share by Regions in 2020
Figure 50. APAC Mesalazine Sales Market Share by Type in 2020
Figure 51. APAC Mesalazine Sales Market Share by Application in 2020
Figure 52. China Mesalazine Revenue Growth 2016-2021 ($ Millions)
Figure 53. Japan Mesalazine Revenue Growth 2016-2021 ($ Millions)
Figure 54. Korea Mesalazine Revenue Growth 2016-2021 ($ Millions)
Figure 55. Southeast Asia Mesalazine Revenue Growth 2016-2021 ($ Millions)
Figure 56. India Mesalazine Revenue Growth 2016-2021 ($ Millions)
Figure 57. Australia Mesalazine Revenue Growth 2016-2021 ($ Millions)
Figure 58. Europe Mesalazine Sales Market Share by Country in 2020
Figure 59. Europe Mesalazine Revenue Market Share by Country in 2020
Figure 60. Europe Mesalazine Sales Market Share by Type in 2020
Figure 61. Europe Mesalazine Sales Market Share by Application in 2020
Figure 62. Germany Mesalazine Revenue Growth 2016-2021 ($ Millions)
Figure 63. France Mesalazine Revenue Growth 2016-2021 ($ Millions)
Figure 64. UK Mesalazine Revenue Growth 2016-2021 ($ Millions)
Figure 65. Italy Mesalazine Revenue Growth 2016-2021 ($ Millions)
Figure 66. Russia Mesalazine Revenue Growth 2016-2021 ($ Millions)
Figure 67. Middle East & Africa Mesalazine Sales Market Share by Country in 2020
Figure 68. Middle East & Africa Mesalazine Revenue Market Share by Country in 2020
Figure 69. Middle East & Africa Mesalazine Sales Market Share by Type in 2020
Figure 70. Middle East & Africa Mesalazine Sales Market Share by Application in 2020
Figure 71. Egypt Mesalazine Revenue Growth 2016-2021 ($ Millions)
Figure 72. South Africa Mesalazine Revenue Growth 2016-2021 ($ Millions)
Figure 73. Israel Mesalazine Revenue Growth 2016-2021 ($ Millions)
Figure 74. Turkey Mesalazine Revenue Growth 2016-2021 ($ Millions)
Figure 75. GCC Country Mesalazine Revenue Growth 2016-2021 ($ Millions)
Figure 76. Channels of Distribution
Figure 77. Distributors Profiles
  • Global Methylprednisolone Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    Methylprednisolone is a corticosteroid medication used to reduce inflammation and suppress The immune system. It is prescribed for a wide range of medical conditions, including autoimmune disorders and inflammatory diseases. The global Methylprednisolone market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. Methylprednisolone is a widely used medication, and The market trend invol......
  • Global Ibuprofen Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 84
    Ibuprofen is an API which is used to produce ibuprofen drugs. Finished drugs ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) derivative of propionic acid used for relieving pain, helping with fever and reducing inflammation. The global Ibuprofen market was valued at US$ 93 million in 2023 and is anticipated to reach US$ 112.3 million by 2030, witnessing a CAGR of 2.7% during The forecast period 2024-2030. Market competition is intense. Xinhua Pharmaceutical, IOLCP,......
  • Global Mesalazine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132
    According to our LPI (LP Information) latest study, the global Mesalazine market size was valued at US$ 158.3 million in 2023. With growing demand in downstream market, the Mesalazine is forecast to a readjusted size of US$ 206 million by 2030 with a CAGR of 3.8% during review period. The research report highlights the growth potential of the global Mesalazine market. Mesalazine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and......
  • Global Drugs For Sinusitis Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Drugs For Sinusitis market size was valued at US$ 2187.4 million in 2023. With growing demand in downstream market, the Drugs For Sinusitis is forecast to a readjusted size of US$ 2827.4 million by 2030 with a CAGR of 3.7% during review period. The research report highlights the growth potential of the global Drugs For Sinusitis market. Drugs For Sinusitis are expected to show stable growth in the future market. However, prod......
  • Global Celecoxib Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Celecoxib market size was valued at US$ 1243.6 million in 2023. With growing demand in downstream market, the Celecoxib is forecast to a readjusted size of US$ 2232 million by 2030 with a CAGR of 8.7% during review period. The research report highlights the growth potential of the global Celecoxib market. Celecoxib are expected to show stable growth in the future market. However, product differentiation, reducing costs, and s......
  • Global Ibuprofen Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 100
    According to our LPI (LP Information) latest study, the global Ibuprofen market size was valued at US$ 91 million in 2023. With growing demand in downstream market, the Ibuprofen is forecast to a readjusted size of US$ 110.4 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Ibuprofen market. Ibuprofen are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supp......
  • Global Ketoprofen Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Ketoprofen market size was valued at US$ 34 million in 2023. With growing demand in downstream market, the Ketoprofen is forecast to a readjusted size of US$ 39 million by 2030 with a CAGR of 2.0% during review period. The research report highlights the growth potential of the global Ketoprofen market. Ketoprofen are expected to show stable growth in the future market. However, product differentiation, reducing costs, and sup......
  • Global Drugs for Sinusitis Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 114
    Market Overview of Global Drugs for Sinusitis market: According to our latest research, the global Drugs for Sinusitis market looks promising in the next 5 years. As of 2022, the global Drugs for Sinusitis market was estimated at USD 2147.6 million, and it's anticipated to reach USD 3206.59 million in 2028, with a CAGR of 6.91% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Dru......
  • Global Ibuprofen Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 91
    According to our (Global Info Research) latest study, the global Ibuprofen market size was valued at USD 96 million in 2023 and is forecast to a readjusted size of USD 114.4 million by 2030 with a CAGR of 2.6% during review period. Ibuprofen is an API which is used to produce ibuprofen drugs. Finished drugs ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) derivative of propionic acid used for relieving pain, helping with fever and reducing inflammation. Market competitio......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs